Advances in Thrombosis and Vascular Biology

A special issue of Biology (ISSN 2079-7737). This special issue belongs to the section "Physiology".

Deadline for manuscript submissions: 31 July 2025 | Viewed by 677

Special Issue Editor


E-Mail
Guest Editor
Laboratory of Blood and Vascular Biology, Rockefeller University, New York, NY 10065, USA
Interests: blood and vascular biology; thrombosis; hemostasis; vascular injury

Special Issue Information

Dear Colleagues,

Hemostasis plays an extremely important role in preventing life-threatening blood loss in response to the disruption of the integrity of blood vessels. After vascular damage, thrombus formation is rapidly initiated to seal the injury. Platelets circulating in the blood are immediately recruited to the site of vascular injury and adhere to the exposed sub-endothelium collagen via the collagen receptor on the platelet surface. The interaction between collagen and its receptor initiates platelet signal transduction and leads to platelet activation and aggregation via the interaction of platelet integrin aIIbb3 and its ligands fibrinogen and von Willebrand factor. Concomitantly, tissue factor activates blood coagulation, which ultimately leads to the generation of thrombin and fibrin. The interaction between fibrin and platelet integrin aIIbb3 induces the process called clot retraction and the formation of stable thrombi. Although hemostasis is a pivotal physiological response and thrombus formation failure results in severe hemorrhagic disorders, excessive or pathological thrombus formation can lead to severe thrombotic diseases, such as myocardial infraction and stroke, which is a major cause of morbidity and mortality worldwide. Thus, thrombus formation must be tightly regulated. With the advancement of new technology and the development of a new thrombosis model, we present recent advances in thrombosis and hemostasis in this Special Issue.

Dr. Lu Wang
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • blood and vascular biology
  • thrombosis
  • hemostasis
  • vascular injury

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

14 pages, 308 KiB  
Review
Biomarkers in Venous Thrombosis: Diagnostic Potential and Limitations
by Yijin Chang, Jiahao Lu and Changsheng Chen
Biology 2025, 14(7), 800; https://doi.org/10.3390/biology14070800 - 1 Jul 2025
Viewed by 426
Abstract
Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT) and pulmonary embolism (PE), is a life-threatening vascular disorder associated with significant morbidity and mortality. Prompt diagnosis is crucial for preventing fatal complications. Current clinical VTE diagnosis predominantly relies on imaging modalities such as compression [...] Read more.
Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT) and pulmonary embolism (PE), is a life-threatening vascular disorder associated with significant morbidity and mortality. Prompt diagnosis is crucial for preventing fatal complications. Current clinical VTE diagnosis predominantly relies on imaging modalities such as compression ultrasound, computed tomography angiography (CTA), and magnetic resonance imaging (MRI). However, these techniques are resource-intensive, time-consuming, and may expose patients to radiation risks. Consequently, the development of highly sensitive and specific biomarkers is imperative to enhance early detection and guide therapeutic interventions. This review examines established and emerging biomarkers in venous thrombosis, evaluates current challenges, and outlines promising future directions for biomarker research in VTE. Full article
(This article belongs to the Special Issue Advances in Thrombosis and Vascular Biology)
Back to TopTop